Inhaled Nitric Oxide in Full-Term and Nearly Full-Term Infants with Hypoxic Respiratory Failure
Author:
- The Neonatal Inhaled Nitric Oxide Study GroupTGThe Neonatal Inhaled Nitric Oxide Study Group
Open Access
- 27 February 1997
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 336 (9) , 597-604
Abstract
Neonates with pulmonary hypertension have been treated with inhaled nitric oxide because of studies suggesting that it is a selective pulmonary vasodilator. We conducted a randomized, multicenter, controlled trial to determine whether inhaled nitric oxide would reduce mortality or the initiation of extracorporeal membrane oxygenation in infants with hypoxic respiratory failure.Keywords
This publication has 28 references indexed in Scilit:
- Prolonged bleeding time during nitric oxide inhalation in the rabbitActa Physiologica Scandinavica, 1994
- Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: Dose responseThe Journal of Pediatrics, 1994
- Bleeding time prolongation and NO inhalationThe Lancet, 1993
- Inhaled Nitric Oxide for the Adult Respiratory Distress SyndromeNew England Journal of Medicine, 1993
- Inhaled Nitric Oxide A Selective Pulmonary Vasodilator of Heparin-Protamine Vasoconstriction in SheepAnesthesiology, 1991
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- Extracorporeal Membrane Oxygenation (ECMO) in Neonatal Respiratory FailureAnnals of Surgery, 1986
- Persistent pulmonary hypertension in the neonate: Diagnosis and managementThe Journal of Pediatrics, 1983
- The independent effects of hyperventilation, tolazoline, and dopamine on infants with persistent pulmonary hypertensionThe Journal of Pediatrics, 1981
- Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 gmThe Journal of Pediatrics, 1978